ST段心肌梗死患者各种原因的死亡率因再灌注治疗类型而异（RYAZAN地区数据，2018-2020）

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

目的：评估ST段抬高型心肌梗死（STEMI）患者的死亡率和全因死亡率，这取决于再灌注治疗的类型。

材料与方法1456例ST段抬高型急性冠脉综合征住院患者中，随机抽取848例进行分析。关于终点（任何原因造成的死亡）的信息收集持续了18个月。目前的数据截至2020年10月1日，随访的中位数为20.8 [17.4; 23.6]个月。

结果。未接受再灌注治疗的患者中，18个月死亡率最高（42.3%）。同时溶栓治疗（TLT）组和未进行再灌注的组在30天内的死亡率没有显着差异（20.3％vs 26.2％，p> 0.05）。经皮冠状动脉介入治疗（PCI）组的住院30天，12个月，18个月全因死亡率分别为8.4％，10.6％，16.6％和18.3％，与对照组相比明显降低。未接受再灌注的患者（分别为19.5％，26.2％，36.2％和42.3％，p <0.05）。达到18个月里程碑时，终点频率的差异最显著：在未再灌注的个体组中，致死率为42.3%，高于TLT组（27.1%）、PCI组（18.3%）和TLT+PCI组（13.1%）。

结果。8个月的随访中，药物介入治疗组和直接PCI组的各种原因的死亡率最低，未接受再灌注治疗组的死亡率最高。

全文:

受限制的访问

作者简介

Elena Parshikova

Lubertsy Regional Hospital

Email: philpoiuy@yandex.ru
ORCID iD: 0000-0003-0349-3456
SPIN 代码: 2809-2781

Head of the Emergency Department

俄罗斯联邦, Lubertsy, Moscow region

Evgenii Filippov

Ryazan State Medical University

编辑信件的主要联系方式.
Email: dr.philippov@gmail.com
ORCID iD: 0000-0002-7688-7176
SPIN 代码: 2809-2781
Researcher ID: O-1490-2016

MD, PhD, Head of the Department of Outpatient Therapy and Preventive Medicine

俄罗斯联邦, Ryazan

参考

  1. Alkhalil M, Choudhury RP. Reperfusion Treatment in Late Presentation Acute Myocardial Infarction: Timing Is Not Everything. Circulation: Cardiovascular Interventions. 2018;11(9):e007287. doi:10. 1161/CIRCINTERVENTIONS.118.007287
  2. Erlikh AD. Six-month outcomes in acute coronary syndrome patients included in the registry Record-3. Russian Journal of Cardiology. 2017;22(11):8-14. (In Russ). doi: 10.15829/1560-4071-2017-11-8-14
  3. Martsevich SYu, Semenova YuV, Kutishenko NP, et al. LIS-3 register of the acute coronary syndrome: what has changed in a «portrait» of a patient and short-term outcomes of the disease compared to LIS-1 register. Rational Pharmacotherapy in Cardiology. 2017;13(1):63-8. (In Russ). doi:10. 20996/1819-6446-2017-13-1-63-68
  4. Kutishenko NP, Kalaydzhyan EP, Sichinava DP, et al. Outpatient registry of patients with acute myocardial infarction (PROFILE-IM): data on prehospital therapy in comparison with the LIS-3 registry. Rational Pharmacotherapy in Cardiology. 2018;14(1):88-93. (In Russ). doi: 10.20996/1819-6446-2018-14-1-88-93
  5. Erlikh AD. Twelve months outcomes in patients with acute coronary syndrome, by the national registry RECORD-3. Russian Journal of Cardiology. 2018;(3):23-30. (In Russ). doi: 10.15829/1560-4071-2018-3-23-30
  6. Russian Statistical Yearbook 2019. Moscow; 2019. Available at: https://rosstat.gov.ru/storage/media-bank/Ejegodnik_2019.pdf. Accessed: 2020 October 27. (In Russ).
  7. Sanchis-Gomar F, Perez-Quilis C, Leischik R, et al. Epidemiology of coronary heart disease and acute coronary syndrome. Annals of Translational Medicine. 2016;4(13):256. doi: 10.21037/atm.2016.06.33
  8. Biery DW, Berman AN, Singh A, et al. Association of Smoking Cessation and Survival Among Young Adults with Myocardial Infarction in the Partners YOUNG-MI Registry. JAMA Network Open. 2020; 3(7):e209649. doi: 10.1001/jamanetworkopen.2020. 9649
  9. Fazel R., Joseph T.I., Sankardas M.A., et al. Comparison of Reperfusion Strategies for ST-Segment-Elevation Myocardial Infarction: A Multivariate Network Meta-analysis. Journal of the American Heart Association. 2020;9(12):e015186. doi:10. 1161/JAHA.119.015186
  10. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119-77. doi: 10.1093/eurheartj/ehx393
  11. Order of the Government of the Ryazan region of 27 June 2019 №301-p «Ob utverzhdenii regional’noy programmy Ryazanskoy oblasti «Bor’ba s serdechno-sosudistymi zabolevaniyami». Available at: http://docs.cntd.ru/document/553385694. Accessed: 2020 October 27. (In Russ).
  12. Peiyuan H, Jingang Y, Haiyan X, et al. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry. PLoS One. 2016; 11(11):e0165672. doi: 10.1371/journal.pone.0165672
  13. Limwattananon C, Jaratpatthararoj J, Thungthong J, et al. Access to reperfusion therapy and mortality outcomes in patients with ST-segment elevation myocardial infarction under universal health coverage in Thailand. BMC Cardiovascular Disorders. 2020;20. doi: 10.1186/s12872-020-01379-3
  14. Lozhkina NG, Khasanova MK, Stafeeva EA, et al. Prediction of remote outcomes of acute myocardial infarction with stable ST-segment elevation on ECG in real clinical practice. Modern Problems of Science and Education. 2018;(6). Available at: http://science-education.ru/ru/article/view?id=28172. Accessed: 2020 October 27. (In Russ).

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Eco-Vector, 2021


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



##common.cookie##